Exendin 9-39 for Gestational Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.
Who Is on the Research Team?
Aoife Egan, MB, BCh, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for pregnant women who have been diagnosed with gestational diabetes. Specific inclusion and exclusion criteria are not listed, but generally participants should be otherwise healthy and able to safely participate in research during pregnancy.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Exendin 9-39
Trial Overview
The study is testing a drug called Exendin 9-39 to see how it affects the pancreas' ability to make insulin during and after pregnancy in women with gestational diabetes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Pregnant participants without gestational diabetes mellitus, matched to the gestational diabetes group by parity, age, ethnicity, gestational week at diagnosis comparator timepoint, and first trimester body mass index.
Pregnant participants diagnosed with gestational diabetes mellitus who complete pregnancy and postpartum metabolic study visits.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.